Cite
Allen JE, Kline CLB, Prabhu VV, et al. Correction: Discovery and clinical introduction of first-in-class imipridone ONC201. Oncotarget. 2021;12(21):2231doi: 10.18632/oncotarget.28012.
Allen, J. E., Kline, C. L. B., Prabhu, V. V., Wagner, J., Ishizawa, J., Madhukar, N., Lev, A., Baumeister, M., Zhou, L., Lulla, A., Stogniew, M., Schalop, L., Benes, C., Kaufman, H. L., Pottorf, R. S., Nallaganchu, B. R., Olson, G. L., Al-Mulla, F., Duvic, M., Wu, G. S., Dicker, D. T., Talekar, M. K., Lim, B., Elemento, O., Oster, W., Bertino, J., Flaherty, K., Wang, M. L., Borthakur, G., Andreeff, M., Stein, M., & El-Deiry, W. S. (2021). Correction: Discovery and clinical introduction of first-in-class imipridone ONC201. Oncotarget, 12(21), 2231. https://doi.org/10.18632/oncotarget.28012
Allen, Joshua E, et al. "Correction: Discovery and clinical introduction of first-in-class imipridone ONC201." Oncotarget vol. 12,21 (2021): 2231. doi: https://doi.org/10.18632/oncotarget.28012
Allen JE, Kline CLB, Prabhu VV, Wagner J, Ishizawa J, Madhukar N, Lev A, Baumeister M, Zhou L, Lulla A, Stogniew M, Schalop L, Benes C, Kaufman HL, Pottorf RS, Nallaganchu BR, Olson GL, Al-Mulla F, Duvic M, Wu GS, Dicker DT, Talekar MK, Lim B, Elemento O, Oster W, Bertino J, Flaherty K, Wang ML, Borthakur G, Andreeff M, Stein M, El-Deiry WS. Correction: Discovery and clinical introduction of first-in-class imipridone ONC201. Oncotarget. 2021 Oct 12;12(21):2231. doi: 10.18632/oncotarget.28012. eCollection 2021 Oct 12. PMID: 34676056; PMCID: PMC8522842.
Copy
Download .nbib
